Inicio>>Signaling Pathways>> Metabolism>> Carbohydrate Metabolism>>2-Chloro-4-nitrophenyl-α-D-glucopyranoside

2-Chloro-4-nitrophenyl-α-D-glucopyranoside (Synonyms: CNPαDglucopyranoside)

Catalog No.GC42137

Carbohydrates conjugated with 2-chloro-4-nitrophenyl (CNP) serve as chromogenic substrates in assays for enzymes that release CNP from the conjugated carbohydrate.

Products are for research use only. Not for human use. We do not sell to patients.

2-Chloro-4-nitrophenyl-α-D-glucopyranoside Chemical Structure

Cas No.: 119047-14-2

Tamaño Precio Disponibilidad Cantidad
10mg
60,00 $
Disponible
50mg
255,00 $
Disponible
100mg
451,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Carbohydrates conjugated with 2-chloro-4-nitrophenyl (CNP) serve as chromogenic substrates in assays for enzymes that release CNP from the conjugated carbohydrate. For example, CNP-β-D-maltoheptaoside and CNP-α-maltotrioside are chromogenic substrates for α-amylase. 2-Chloro-4-nitrophenyl-α-D-glucopyranoside is a conjugate of CNP and α-D-glucose. The related conjugate between CNP and β-D-glucose, 2-chloro-4-nitrophenyl β-D-glucopyranoside, is used as a chromogenic substrate for glycosyltransferases. This product is a chromogenic substrate for enzymes that target the linkage between CNP and α-D-glucose.

Reseñas

Review for 2-Chloro-4-nitrophenyl-α-D-glucopyranoside

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 2-Chloro-4-nitrophenyl-α-D-glucopyranoside

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.